Synthesis, Crystal Structure and Biological Characterization of a Novel Palladium(II) Complex with a Coumarin‐Derived Ligand
暂无分享,去创建一个
[1] S. J. Grabowski,et al. Crystal and molecular structures of 3-[1-(2-hydroxyethylamino)-ethylidene]-chroman-2,4-dione and 2-methoxy-3-[1-(benzylamino)-ethylidene]-2,3-dihydro-2,4-dioxo-2λ5-benzo[e][1,2]oxaphosphinane and DFT study of intramolecular H-bonds of related compounds , 2004 .
[2] M. Różalski,et al. Cytotoxic effects, alkylating properties and molecular modelling of coumarin derivatives and their phosphonic analogues. , 2003, European journal of medicinal chemistry.
[3] E. Nawrot,et al. Synthesis, antimicrobial, and alkylating properties of 3‐phosphonic derivatives of chromone , 2001, Archiv der Pharmazie.
[4] B. J. Kim,et al. Classification of CD and absorption spectra in the Soret band of H(2)TMPyP bound to various synthetic polynucleotides. , 2001, Biophysical chemistry.
[5] M. Małecka,et al. Investigations on benz[1,2]oxaphosphinane derivatives. , 2001, Acta crystallographica. Section C, Crystal structure communications.
[6] I. Kostova,et al. Synthesis, Physicochemical Characterization, and Cytotoxic Screening of New Zirconium Complexes with Coumarin Derivatives , 2001, Archiv der Pharmazie.
[7] Mohamed R. Shehata,et al. Mixed ligand complexes of diaquo (2,2′-bipyridine)palladium(II) with cyclobutane-1,1-dicarboxylic acid and DNA constituents , 2001 .
[8] T. Netzeva,et al. Cytotoxic Activity of Cerium Complexes with Coumarin Derivatives. Molecular Modeling of the Ligands , 2000, Archiv der Pharmazie.
[9] S. Rajski,et al. DNA Cross-Linking Agents as Antitumor Drugs. , 1998, Chemical reviews.
[10] L. Rashan,et al. Synthesis and cytotoxic evaluation of the first trans-palladium(II) complex with naturally occurring alkaloid harmine , 1998 .
[11] R. Fawzi,et al. Chemical properties and cytotoxic activity of complexes of platinum(II) and palladium(II) containing dmso and various anions; synthesis and structural characterization of [Pt(dmso)2{O2(CO)2CCH2CH2CH2}] , 1998 .
[12] J. Perez,et al. Novel tetranuclear orthometalated complexes of Pd(II) and Pt(II) derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxic activity in cis-DDP resistant tumor cell lines. Interaction of these complexes with DNA. , 1998, Journal of medicinal chemistry.
[13] C. Siegers,et al. Antitumor-activities of coumarin, 7-hydroxy-coumarin and its glucuronide in several human tumor cell lines. , 1998, Research communications in molecular pathology and pharmacology.
[14] E. De Clercq,et al. Palladium(II) complexes of dialkyl alpha-Anilinobenzylphosphonates. Synthesis, characterization, and cytostatic activity. , 1996, Journal of inorganic biochemistry.
[15] P. Sohár,et al. Tricarbonylmethane acylhydrazones: Reactions under acylating conditions and formation of fused isoxazole derivatives with concomitant NN bond cleavage , 1995 .
[16] S. Fricker,et al. Synthesis and cytotoxicity of some cyclometallated palladium complexes. , 1993, Journal of inorganic biochemistry.
[17] M. F. Richardson,et al. Palladium and platinum complexes with vitamin B6 compounds , 1992 .
[18] P. Gans,et al. Mathematical algorithms and computer programs for the determination of equilibrium constants from potentiometric and spectrophotometric measurements , 1992 .
[19] M. Hansen,et al. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.
[20] D. Lydall,et al. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA. , 1986, Cancer research.
[21] P. Loehrer,et al. Drugs five years later. Cisplatin. , 1984, Annals of internal medicine.
[22] G. Coppola,et al. An Improved Synthesis of 2-Methylchromone-3-carboxylic Acid and Its Esters , 1981 .
[23] J. Trosko,et al. Platinum Compounds: a New Class of Potent Antitumour Agents , 1969, Nature.
[24] S. Kirschner,et al. Anticancer and potential antiviral activity of complex inorganic compounds. , 1966, Journal of medicinal chemistry.
[25] I. Levine. Structure of Formaldoxime , 1963 .
[26] M. Jakupec,et al. Tumour-inhibiting platinum complexes--state of the art and future perspectives. , 2003, Reviews of physiology, biochemistry and pharmacology.
[27] G. Mazur,et al. Comparison of pharmacological and clinical activity between cisplatin and carboplatin in the treatment of solid tumours , 2000 .
[28] I. Kostova,et al. Synthesis, physicochemical characterisation and cytotoxic screening of new complexes of cerium, lanthanum and neodymium with Warfarin and Coumachlor sodium salts , 1999 .
[29] J. Reedijk. Improved understanding in platinium antitumour chemistry , 1996 .
[30] B. Keppler. Metal complexes in cancer chemotherapy , 1993 .
[31] R. Ratliff,et al. Circular dichroism spectroscopy of DNA. , 1992, Methods in enzymology.
[32] L. Rashan,et al. Synthesis and characterization of novel biologically active platinum(II) and palladium(II) complexes of some β-carboline alkaloids , 1990 .
[33] L. Pettit,et al. Complex formation between palladium(II) and amino acids, peptides and related ligands , 1985 .
[34] J. Reedijk,et al. Coordination compounds of Pt(II) and Pd(II) with imidazole as a ligand. New synthetic procedures and characterization , 1979 .
[35] G. D. Rieck,et al. International tables for X-ray crystallography , 1962 .